Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
CONCLUSIONS: In contrast with SEV, SFOH did not appear to impact the iPTH-lowering effect of oral VDRAs.
PMID: 27434393 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Sprague SM, Covic AC, Floege J, Ketteler M, Botha J, Chong EM, Rastogi A Tags: Am J Nephrol Source Type: research
More News: Chronic Kidney Disease | Dialysis | Hormones | Hyperparathyroidism | Renvela | Study | Urology & Nephrology | Vitamins